Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-12-20 4:30 pm Sale | 13D | Eterna Therapeutics Inc. ERNA | Singer Nicholas Jason | 393,766 7.67% | -1,701,234![]() (-81.20%) | View |
2022-12-14 4:30 pm Purchase | 13D | Eterna Therapeutics Inc. ERNA | Cherington Charles | 567,526 11.05% | 567,526![]() (New Position) | View |
2022-12-05 5:20 pm Sale | 13G | Eterna Therapeutics Inc. ERNA | HALPERN JOHN D | 451,166 8.8% | -4,296,079![]() (-90.50%) | View |
2022-12-02 5:01 pm Purchase | 13G | Eterna Therapeutics Inc. ERNA | Freebird Partners LP | 272,583 5.3% | 272,583![]() (New Position) | View |
2022-03-16 4:30 pm Sale | 13D | Eterna Therapeutics Inc. ERNA | Cherington Charles | 5,913,365 11.4% | -399,932![]() (-6.33%) | View |
2022-02-16 5:15 pm Sale | 13G | Eterna Therapeutics Inc. ERNA | Singer Nicholas Jason | 2,095,000 4% | -1,696,983![]() (-44.75%) | View |
2021-08-27 5:26 pm Purchase | 13G | Eterna Therapeutics Inc. ERNA | Factor Bioscience Inc. | 4,670,980 9% | 4,670,980![]() (New Position) | View |
2021-05-26 10:05 am Sale | 13G | Eterna Therapeutics Inc. ERNA | Custard & Pitts Investment Co. LP | 1,839,521 4.43% | -250,000![]() (-11.96%) | View |
2021-05-24 1:03 pm Purchase | 13G | Eterna Therapeutics Inc. ERNA | HALPERN JOHN D | 4,747,245 11.4% | 4,747,245![]() (New Position) | View |
2021-05-18 11:48 am Purchase | 13G | Eterna Therapeutics Inc. ERNA | Custard & Pitts Investment Co. LP | 2,089,521 5.03% | 2,089,521![]() (New Position) | View |
2021-05-13 5:00 pm Purchase | 13G | Eterna Therapeutics Inc. ERNA | DENNY GEORGE P III | 4,907,992 11.8% | 4,907,992![]() (New Position) | View |
2021-05-13 5:00 pm Purchase | 13D | Eterna Therapeutics Inc. ERNA | Cherington Charles | 6,313,297 15.2% | 6,313,297![]() (New Position) | View |
2021-05-04 10:37 am Unchanged | 13G | Eterna Therapeutics Inc. ERNA | GENTILE GUY | 0 0% | 0 (Unchanged) | View |
2021-04-30 4:05 pm Purchase | 13G | Eterna Therapeutics Inc. ERNA | Singer Nicholas Jason | 3,791,983 9.13% | 3,791,983![]() (New Position) | View |
2021-03-17 4:30 pm Sale | 13D | Eterna Therapeutics Inc. ERNA | Ault Alliance Inc. AULT | 81,826 2.75% | -111,230![]() (-57.62%) | View |
2021-03-16 4:30 pm Sale | 13D | Eterna Therapeutics Inc. ERNA | Ault Alliance Inc. AULT | 193,056 6.49% | -101,944![]() (-34.56%) | View |
2021-02-22 4:30 pm Unchanged | 13D | Eterna Therapeutics Inc. ERNA | Ault Alliance Inc. AULT | 295,000 9.96% | 0 (Unchanged) | View |
2021-02-16 5:18 pm Purchase | 13G | Eterna Therapeutics Inc. ERNA | GENTILE GUY | 175,000 5.91% | 175,000![]() (New Position) | View |
2021-02-12 1:37 pm Sale | 13G | Eterna Therapeutics Inc. ERNA | BARD ASSOCIATES INC | 0 0% | -271,850![]() (Position Closed) | View |
2021-01-29 4:25 pm Purchase | 13D | Eterna Therapeutics Inc. ERNA | Ault Alliance Inc. AULT | 295,000 9.96% | 295,000![]() (New Position) | View |